Plato Investment Management’s Boston Scientific BSX Stock Holding History

Plato Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.71M	Buy	43,172 +466	+1%	+$37.3K	0.18%	126
2025 Q4	$4.09M	Buy	42,706 +14,144	+50%	+$1.39M	0.27%	84
2025 Q3	$2.77M	Buy	28,562 +6,487	+29%	+$672K	0.19%	114
2025 Q2	$2.36M	Buy	22,075 +944	+4%	+$95.5K	0.18%	122
2025 Q1	$2.15M	Buy	21,131 +2,061	+11%	+$208K	0.18%	135
2024 Q4	$1.71M	Buy	19,070 +319	+2%	+$28.1K	0.13%	176
2024 Q3	$1.57M	Hold	18,751	–	–	0.13%	183
2024 Q2	$1.44M	Buy	18,751 +1,391	+8%	+$102K	0.13%	162
2024 Q1	$1.19M	Buy	17,360 +15,804	+1,016%	+$1.02M	0.12%	184
2023 Q4	$90K	Buy	+1,556	New	+$83.1K	0.11%	167

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Plato Investment Management's BSX Position: Q1 2026 in Review

Plato Investment Management increased its Boston Scientific (BSX) stake by 1.1% in Q1 2026, buying an estimated $37.3K and bringing the position to 43,172 shares worth $2.71M. The position accounts for 0.18% of the portfolio, ranked #126.

Plato Investment Management first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.09M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Plato Investment Management held 43,172 shares of Boston Scientific worth $2.71M as of Q1 2026.
Plato Investment Management bought 466 Boston Scientific shares in Q1 2026, an estimated $37.3K.
Boston Scientific made up 0.18% of Plato Investment Management's portfolio in Q1 2026, its #126 holding.
Plato Investment Management first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Plato Investment Management's Boston Scientific position peaked at $4.09M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.